{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:53:34Z","timestamp":1780732414284,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ijcard.2011.10.133","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T19:34:57Z","timestamp":1321990497000},"page":"448-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types of calcium channel blockers"],"prefix":"10.1016","volume":"166","author":[{"given":"Tadashi","family":"Konoshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasukazu","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Wakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Inoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Miyamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2011.10.133_bb0220","first-page":"S1","article-title":"clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"K\/DOQI","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0010","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0015","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1751-7176.2009.00184.x","article-title":"Pathogenesis and treatment of microalbuminuria in patients with diabetes: the road ahead","volume":"11","author":"Kalaitzidis","year":"2009","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0020","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1046\/j.1523-1755.2003.00033.x","article-title":"Retarding progression of chronic renal disease: the neglected issue of residual proteinuria","volume":"63","author":"Ruggenenti","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0025","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","article-title":"Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy","volume":"110","author":"de Zeeuw","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0225","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0035","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0040","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1046\/j.1523-1755.1998.00083.x","article-title":"Effects of an ACE inhibitor\/calcium antagonist combination on proteinuria in diabetic nephropathy","volume":"54","author":"Bakris","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0045","first-page":"229","article-title":"Molecular genetics of the renin\u2013angiotensin\u2013aldosterone system in human hypertension","volume":"45","author":"Corvol","year":"1997","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0050","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/01.hjh.0000165623.72310.dd","article-title":"The cardiovascular continuum and renin\u2013angiotensin\u2013aldosterone system blockade","volume":"23","author":"Dzau","year":"2005","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0055","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/en.2006-1287","article-title":"Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio","volume":"148","author":"Wakahara","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0060","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2337\/diacare.29.04.06.dc05-1873","article-title":"Tissue gene expression of renin\u2013angiotensin system in human type 2 diabetic nephropathy","volume":"29","author":"Konoshita","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0065","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/ki.1996.466","article-title":"Evidence that renal and chorionic tissues contain similar nuclear binding proteins that recognize the human renin promoter","volume":"50","author":"Konoshita","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1042\/bj3160107","article-title":"Transcriptional induction of the human renin gene by cyclic AMP requires cyclic AMP response element-binding protein (CREB) and a factor binding a pituitary-specific trans-acting factor (Pit-1) motif","volume":"316","author":"Germain","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00004872-200302000-00024","article-title":"Implication of Ref-1 in the repression of renin gene transcription by intracellular calcium","volume":"21","author":"Fuchs","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jcb.20151","article-title":"Candidate cis-elements for human renin gene expression in the promoter region","volume":"93","author":"Konoshita","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0085","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/jcb.21341","article-title":"A proximal direct repeat motif characterized as a negative regulatory element in the human renin gene","volume":"102","author":"Konoshita","year":"2007","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0090","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.cellbio.16.1.521","article-title":"Structure and regulation of voltage-gated Ca2+ channels","volume":"16","author":"Catterall","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0896-6273(00)81057-0","article-title":"Nomenclature of voltage-gated calcium channels","volume":"25","author":"Ertel","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1755-5922.2009.00079.x","article-title":"Cilnidipine: a new generation ca channel blocker with inhibitory action on sympathetic neurotransmitter release","volume":"27","author":"Takahara","year":"2009","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0230","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1053\/j.ajkd.2006.12.005","article-title":"Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease","volume":"49","author":"KDOQI","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0110","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1536\/ihj.49.723","article-title":"Vasodilatory effect of cilnidipine, an L-type and N-type calcium channel blocker, on rat kidney glomerular arterioles","volume":"49","author":"Konno","year":"2008","journal-title":"Int Heart J"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0115","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.RES.0000256155.31133.49","article-title":"Ca2+ channel subtypes and pharmacology in the kidney","volume":"100","author":"Hayashi","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0120","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00004872-200502000-00028","article-title":"Controlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi (Nifedipine and Candesartan Combination) Study","volume":"23","author":"Hasebe","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.ki.5000349","article-title":"Comparison between valsartan and valsartan plus cilnidipine in type II diabetics with normo- and microalbuminuria","volume":"70","author":"Katayama","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jdiacomp.2006.06.001","article-title":"Renoprotective effect of N-type Ca channel blockade in diabetic nephropathy","volume":"21","author":"Fujisawa","year":"2007","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0135","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/sj.ki.5002623","article-title":"Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin\u2013angiotensin inhibition in hypertensive patients with chronic renal disease","volume":"72","author":"Fujita","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0140","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1097\/HJH.0b013e3282c2fa62","article-title":"Renal and vascular protective effects of cilnidipine in patients with essential hypertension","volume":"25","author":"Morimoto","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0145","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/HYPERTENSIONAHA.110.157149","article-title":"Morning surge in blood pressure and cardiovascular risk: evidence and perspectives","volume":"56","author":"Kario","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000085713","article-title":"The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome","volume":"101","author":"Konda","year":"2005","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000210396","article-title":"Different effects of L\/N-type and L-type calcium channel blockers on the renin\u2013angiotensin\u2013aldosterone system in SHR\/Izm","volume":"30","author":"Konda","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0160","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1097\/HJH.0b013e32833d01dd","article-title":"A new-generation N\/L-type calcium channel blocker leads to less activation of the renin\u2013angiotensin system compared with conventional L type calcium channel blocker","volume":"28","author":"Konoshita","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1126\/science.2447647","article-title":"Dominant role of N-type Ca2+ channels in evoked release of norepinephrine from sympathetic neurons","volume":"239","author":"Hirning","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.bjp.0701342","article-title":"Blockade of N-type Ca2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurones","volume":"122","author":"Uneyama","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0021-5198(19)31344-7","article-title":"Cilnidipine attenuates renal nerve stimulation-induced renal vasoconstriction and antinatriuresis in anesthetized dogs","volume":"75","author":"Takahara","year":"1997","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0180","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/HJH.0b013e328336ade3","article-title":"Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte","volume":"28","author":"Fan","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0185","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1210\/en.2008-1624","article-title":"Regulation of aldosterone and cortisol production by the transcriptional repressor neuron restrictive silencer factor","volume":"150","author":"Somekawa","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0190","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/HYPERTENSIONAHA.107.103580","article-title":"A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity","volume":"51","author":"Dietz","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000045633","article-title":"Calcium channel blockers inhibit proliferation and matrix production in rat mesangial cells: possible mechanism of suppression of AP-1 and CREB activities","volume":"85","author":"Sugiura","year":"2000","journal-title":"Nephron"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0200","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/S0024-3205(00)00849-3","article-title":"Nifedipine inhibits activation of transcription factor NF-kappaB","volume":"67","author":"Matsumori","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0205","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJMoa1007994","article-title":"Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes","volume":"364","author":"Haller","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0210","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/01.HYP.37.5.1268","article-title":"Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model","volume":"37","author":"Griffin","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2011.10.133_bb0215","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2337\/dc09-0348","article-title":"Genetic variant of the renin\u2013angiotensin system and diabetes influences blood pressure response to angiotensin receptor blockers","volume":"32","author":"Konoshita","year":"2009","journal-title":"Diabetes Care"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527311020249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527311020249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:32:40Z","timestamp":1759091560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527311020249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0167527311020249"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2011.10.133","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types of calcium channel blockers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2011.10.133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}